Human kallikrein 8 (hK8/TADG-14) expression is associated with an early clinical stage and favorable prognosis in ovarian cancer

Oncology Reports

Volumn 11, Issue 6, 2004, Pages 1153-1159

  Shigemasa, Kazushi ^a   Tian, Xiurong ^a   Gu, Lijun ^a   Tanimoto, Hirotoshi ^b   Underwood, Lowell J ^c   O'Brien, Timothy J ^d   Ohama, Koso ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

^b National Hiroshima Hospital   (Japan)

^c UNIVERSITY OF ARKANSAS   (United States)

^d UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

hK8; Immunohistochemistry; KLK8; Ovarian cancer; Semiquantitative PCR; TADG 14

Indexed keywords

KALLIKREIN; KLK8 PROTEIN, HUMAN; MESSENGER RNA; TUMOR MARKER;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; CANCER STAGING; CASE CONTROL STUDY; COMPARATIVE STUDY; DISEASE COURSE; ENDOMETRIOID CARCINOMA; ENZYME IMMUNOASSAY; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; MIDDLE AGED; NEOPLASM; OVARY; OVARY TUMOR; PATHOLOGY; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURVIVAL RATE;

ADENOCARCINOMA, CLEAR CELL; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, ENDOMETRIOID; CASE-CONTROL STUDIES; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOENZYME TECHNIQUES; KALLIKREINS; MIDDLE AGED; NEOPLASM STAGING; NEOPLASMS, CYSTIC, MUCINOUS, AND SEROUS; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; OVARY; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 8144227602     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.11.6.1153     Document Type: Article

References (27)

1. Neorath H: The diversity of proteolytic enzymes. In: Proteolytic Enzymes. Beynon RJ and Bond JS (eds). IRL Press, Oxford, pp1-13, 1989.
2. Liotta LA, Steeg PS and Stetler-Stevenson WG: Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell 64: 327-336, 1991. (Pubitemid 121001258)
3. Duffy MJ: The role of proteolytic enzymes in cancer invasion and metastasis. Clin Exp Metastasis 10: 145-155, 1992.
4. Tryggvason K, Hoyhtya M and Salo T: Proteolytic degradation of extracellular matrix in tumor invasion. Biochim Biophys Acta 907: 191-217, 1987. (Pubitemid 18005336)
5. Yousef GM and Diamandis EP: The new human tissue kallikrein gene family: structure, function, and association to disease. Endocr Rev 22: 184-204, 2001. (Pubitemid 32458158)
6. Diamandis EP and Yousef GM: Human tissue kallikreins: a family of new cancer biomarkers. Clin Chem 48: 1198-1205, 2002. (Pubitemid 34809825)
7. Diamandis EP, Yousef GM, Clements J, et al: New nomenclature for the human tissue kallikrein gene family. Clin Chem 46: 1855-1858, 2000.
8. Tanimoto H, Underwood LJ, Shigemasa K, Parmley TH and O'Brien TJ: Increased expression of protease M in ovarian tumors. Tumour Biol 22: 11-18, 2001.
9. Tanimoto H, Underwood LJ, Shigemasa K, et al: The stratum corneum chymotryptic enzyme that mediates shedding and desquamation of skin cells is highly overexpressed in ovarian tumor cells. Cancer 86: 2074-2082, 1999.
10. Underwood LJ, Tanimoto H, Wang Y, Shigemasa K, Parmley TH and O'Brien TJ: Cloning of tumor-associated differentially expressed gene-14, a novel serine protease overexpressed by ovarian carcinoma. Cancer Res 59: 4435-4439, 1999. (Pubitemid 29418765)
11. Yoshida S, Taniguchi M, Hirata A and Shiosaka S: Sequence analysis and expression of human neuropsin cDNA and gene. Gene 213: 9-16, 1998. (Pubitemid 28284717)
12. Yoshida S and Shiosaka S: Plasticity-related serine proteases in the brain. Int J Mol Med 3: 405-409, 1999.
13. Suzuki J, Yoshida S, Chen ZL, et al: Ontogeny of neuropsin mRNA expression in the mouse brain. Neurosci Res 23: 345-351, 1995.
14. Magklara A, Scorilas A, Katsaros D, et al: The human KLK8 (Neuropsin/Ovasin) gene: identification of two novel splice variants and its prognostic value in ovarian cancer. Clin Cancer Res 7: 806-811, 2001. (Pubitemid 32708714)
15. Parker SL, Tong T, Bolden S and Wingo PA: Cancer statistics. CA Cancer J Clin 46: 5-27, 1996.
16. Russel P: Surface epithelial-stromal tumors of the ovary. In: Blaustein's Pathology of the Female Genital Tract. Kurman RJ (ed). Springer-Verlag, New York, pp705-782, 1995.
17. Benedet JL, Bender H, Jones H III, Ngan HYS and Pecorelli S: FIGO staging classifications and clinical practice guidelines in the management of gynecological cancers. International Federation of Gynecology and Obstetrics (FIGO) Committee on Gynecologic Oncology. Int J Gynecol Obstet 70: 209-262, 2000.
18. Shigemasa K, Hu C, West CM, et al: p16 overexpression: a potential early indicator of transformation in ovarian carcinoma. J Soc Gynecol Invest 4: 95-102, 1997. (Pubitemid 27173242)
19. Shigemasa K, Hu C, West CM, et al: p21: a monitor of p53 dysfunction in ovarian neoplasia. Int J Gynecol Cancer 7: 296-303, 1997. (Pubitemid 27458975)
20. Shigemasa K, Underwood LJ, Beard J, et al: Overexpression of testisin, a serine protease expressed by testicular germ cells, in epithelial ovarian tumor cells. J Soc Gynecol Invest 7: 358-362, 2000.
21. Obiezu CV, Scorilas A, Katsaros D, et al: Higher human kallikrein gene 4 (KLK4) expression indicates poor prognosis of ovarian cancer patients. Clin Cancer Res 7: 2380-2386, 2001.
22. Dong Y, Kaushal A, Bui L, et al: Human kallikrein 4 (KLK4) is highly expressed in serous ovarian carcinomas. Clin Cancer Res 7: 2363-2371, 2001. (Pubitemid 32751637)
23. Kim H, Scorilas A, Katsaros D, et al: Human kallikrein gene 5 (KLK5) expression is an indicator of poor prognosis in ovarian cancer. Br J Cancer 84: 643-650, 2001. (Pubitemid 32238998)
24. Yousef GM, Scorilas A, Kyriakopoulou LG, et al: Human kallikrein gene 5 (KLK5) expression by quantitative PCR: an independent indicator of poor prognosis in breast cancer. Clin Chem 48: 1241-1250, 2002. (Pubitemid 34809832)
25. Yousef GM, Kyriakopoulou LG, Scorilas A, et al: Quantitative expression of the human kallikrein gene 9 (KLK9) in ovarian cancer: a new independent and favorable prognostic marker. Cancer Res 61: 7811-7818, 2001. (Pubitemid 33049369)
26. Chang A, Yousef GM, Scorilas A, et al: Human kallikrein gene 13 (KLK13) expression by quantitative RT-PCR: an independent indicator of favourable prognosis in breast cancer. Br J Cancer 86: 1457-1464, 2002. (Pubitemid 34548070)
27. Kishi T, Grass L, Soosaipillai A, et al: Human kallikrein 8, a novel biomarker for ovarian carcinoma. Cancer Res 63: 2771-2774, 2003. (Pubitemid 36667147)